Overexpression of RECQL4 in more than half of the seven gastric cancer cell lines analyzed, were not only associated with poor prognosis but also with enhanced resistance to cisplatin via the downstream AKT-YB1-MDR1 signaling pathway (Mo et al., 2016). The gene discussed is RECQL4; the disease is gastric cancer.